Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

AzaSite Plus begins phase I safety study

Nov. 10, 2006

No Comments

OcuCure uses seed funding to advance compounds for AMD

Nov. 10, 2006

No Comments

CGC-11047 studied in patients with AMD

Nov. 10, 2006

No Comments

Lux licenses ciclosporin-eluting silicone matrix ocular implant from NIH

Nov. 9, 2006

No Comments

MacuSight's proprietary sirolimus formulation begins phase I study in wet AMD

Nov. 6, 2006

No Comments

TG-100801 for ocular diseases studied in phase I

Nov. 3, 2006

No Comments

Recent PhotoBioChem patent describes new porphyrin derivatives for AMD

Oct. 30, 2006

No Comments

Bayer and Regeneron to collaborate on VEGF Trap-Eye

Oct. 23, 2006

No Comments

BVT-28949 begins phase II study for glaucoma

Oct. 18, 2006

No Comments

Phase III trial of NOVA-22007 in vernal keratoconjunctivitis completes enrollment

Oct. 9, 2006

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

AzaSite Plus begins phase I safety study

OcuCure uses seed funding to advance compounds for AMD

CGC-11047 studied in patients with AMD

Lux licenses ciclosporin-eluting silicone matrix ocular implant from NIH

MacuSight's proprietary sirolimus formulation begins phase I study in wet AMD

TG-100801 for ocular diseases studied in phase I

Recent PhotoBioChem patent describes new porphyrin derivatives for AMD

Bayer and Regeneron to collaborate on VEGF Trap-Eye

BVT-28949 begins phase II study for glaucoma

Phase III trial of NOVA-22007 in vernal keratoconjunctivitis completes enrollment

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Abbvie and Simcere enter a $1B T-cell engager deal

Proteomics study explores how protein changes influence disease

Ocular RSS

Ocular
RSS